2016
DOI: 10.3748/wjg.v22.i18.4594
|View full text |Cite
|
Sign up to set email alerts
|

Calcium supplementation for the prevention of colorectal adenomas: A systematic review and meta-analysis of randomized controlled trials

Abstract: Our results suggest a modest chemopreventive effect of calcium supplements against recurrent colorectal adenomas over a period of 36 to 60 mo. Further research is warranted.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
29
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 42 publications
(29 citation statements)
references
References 67 publications
0
29
0
Order By: Relevance
“…In a 2016 meta-analysis of 4 randomized, controlled trials of the efficacy of supplemental calcium on reducing colorectal adenoma recurrence, the summary RR was 0.89 (95% CI, 0.82-0.96; ref. 42). In a 2014 meta-analysis of 4 prospective cohort studies of a magnesium-colorectal cancer association, the summary RR among those in the highest relative to the lowest category of magnesium intake was 0.78 (95% CI, 0.66-0.92; ref.…”
Section: Discussionmentioning
confidence: 99%
“…In a 2016 meta-analysis of 4 randomized, controlled trials of the efficacy of supplemental calcium on reducing colorectal adenoma recurrence, the summary RR was 0.89 (95% CI, 0.82-0.96; ref. 42). In a 2014 meta-analysis of 4 prospective cohort studies of a magnesium-colorectal cancer association, the summary RR among those in the highest relative to the lowest category of magnesium intake was 0.78 (95% CI, 0.66-0.92; ref.…”
Section: Discussionmentioning
confidence: 99%
“…[ 6 8 ] The results of previous meta-analyses regarding the association between calcium intake and colorectal adenoma risk have not always been consistent. [ 8 12 ] Four previous meta-analyses of RCTs [ 8 11 ] that have examined the effect of supplemental calcium compared with placebo on adenoma recurrence demonstrated moderate to larger protective effects (20–26% relative risk reduction). However, the latest one [ 12 ] does not demonstrate a greater protective effect (only 11–13% relative risk reduction) for calcium.…”
Section: Introductionmentioning
confidence: 99%
“…Meta-analyses including the latest one, merely considered some bias components, [ 10 ] included trials with high or unclear risk of bias in the meta-analyses [ 10 , 12 ] and did not GRADE the evidence. [ 9 11 ] It is recommended that review authors do not combine studies at different risk of bias in analyses.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Recent randomized controlled trials (RCTs)16,17 have demonstrated the moderate beneficial effect of low-dose aspirin on the incidence of adenomas. Similarly, evidence from good quality RCTs4648 suggests a possible protective effect of calcium supplementation on the recurrence of adenomas, without important adverse effects 49. However, evidence of the comparative advantage of low-dose aspirin and calcium with other potential CPAs on adenoma recurrence is necessary to justify the continuous growth of these agents in this era of stagnant screening acceptance,9,50 limited endoscopic capacity51 and rising health care expenditures 52…”
Section: Introductionmentioning
confidence: 99%